Understanding the Mechanisms of FHIT Inactivation in Cervical Cancer for Biomarker Development
- 1 July 2004
- journal article
- research article
- Published by Springer Nature in Journal of the Society for Gynecologic Investigation
- Vol. 11 (5) , 329-337
- https://doi.org/10.1016/j.jsgi.2003.12.008
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Restored Expression of Fragile Histidine Triad Protein and Tumorigenicity of Cervical Carcinoma CellsJNCI Journal of the National Cancer Institute, 2000
- FHIT alterations in cancerous and non-cancerous cervical epitheliumInternational Journal of Cancer, 1999
- THE ROLE OF THE FHIT/FRA3B LOCUS IN CANCERAnnual Review of Genetics, 1998
- Abnormalities of fragile histidine triad genomic and complementary DNAs in cervical cancer: association with human papillomavirus type.JNCI Journal of the National Cancer Institute, 1998
- Fhit, a Putative Tumor Suppressor in Humans, Is a Dinucleoside 5‘,5‘ ‘‘-P1,P3-Triphosphate HydrolaseBiochemistry, 1996